Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis

DNA and Cell Biology

Volumn 27, Issue 4, 2008, Pages 199-207

  Chang Hong, Shi ^a   Xiao Wu, Wang ^a   Hai, Zhang ^a   Ting Fen, Zhang ^a   Li Mei, Wang ^a   Zhi Kai, Xu ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DNA VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 2; PLASMID DNA; PROTEIN AG85B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINANT PLASMID; SPLEEN LYMPHOCYTE; TUBERCULOSIS; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CELL LINE; CELL PROLIFERATION; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-2; LUNG; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEINS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, DNA;

MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 42149175510     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2007.0648     Document Type: Article

References (29)

1. Brandt, L., Oettinger, T., Holm, A., Andersen, A.B., and Andersen, P. (1996). Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 157, 3527-3533.
2. Cai, H., Hu, X.D., Yu, D.H., Li, S.X., Tian, X., and Zhu, Y.X. (2005). Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice. Vaccine 23, 4167-4174.
3. Cai, H., Yu, D.H., Hu, X.D., Li, S.X., and Zhu, Y.X. (2006). A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge. DNA Cell Biol 25, 438-447.
4. Denis, O., Tanghe, A., Palfliet, K., Jurion, F., van den Berg, T.P., Vanonckelen, A., Ooms, J., Saman, E., Ulmer, J.B., Content, J., and Huygen, K. (1998). Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by M. tuberculosis H37Rv infection. Infect Immun 66, 1527-1533.
5. Derrick, S.C., Repique, C., Snoy, P., Yang, A.L., and Morris, S. (2004). Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis. Infect Immun 72, 1685-1692.
6. Derrick, S.C., Yang, A.L., and Morris, S.L.A. (2004). Polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 23, 780-788.
7. Dietrich, J., Aagaard, C., Leah, R., Olsen, A.W., Stryhn, A., Doherty, T.M., and Andersen, P. (2005). Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 174, 6332-6339.
8. Dietrich, J., Weldingh, K., and Andersen, P. (2006). Prospects for a novel vaccine against tuberculosis. Vet Microbiol 112, 163-169.
9. Dye, C., Scheele, S., Dolin, P., Pathania, V., and Raviglione, M.C. (1999). Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282, 677-686.
10. Feng, C.G., Palendira, U., Demangel, C., Spratt, J.M., Malin, A.S., and Britton, W.J. (2001). Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis. Infect Immun 69, 4174-4176.
11. Hogarth, P.J., Logan, K.E., Vordermeier, H.M., Singh, M., Hewinson, R.G., and Chambers, M.A. (2005). Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c - a member of the esat-6 gene family. Vaccine 23, 2557-2564.
12. Kamath, A.T., Feng, C.G., Macdonald, M., Briscoe, H., and Britton, W.J. (1999). Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 67, 1702-1707.
13. Li, H., Li, R., Zhong, S., Ren, H., Zou, Y., Chen, X., Shi, X., Wang, M., Long, H., and Luo, Y. (2006). The immunogenicity and protective efficacy of Mtb8.4=hIL-12 chimeric gene vaccine. Vaccine 24, 1315-1323.
14. Mathiesen, I. (1999). Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 6, 508-514.
15. Mattow, J., Schaible, U.E., Schmidt, F., Hagens, K., Siejak, F., Brestrich, G., Haeselbarth, G., Muller, E.C., Jungblut, P.R., and Kaufmann, S.H. (2003). Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen. Electrophoresis 24, 3405-3420.
16. Mhalu, F.S. (2005). Burden of diseases in poor resource countries: meeting the challenges of combating HIV=AIDS, tuberculosis and malaria. Tanzan Health Res Bull 7, 179-184.
17. Morris, S., Kelley, C., Howard, A., Li, Z., and Collins, F. (2000). The immunogenicity of single and combination DNA vaccines against tuberculosis. Vaccine 18, 2155-2163.
18. Olsen, A.W., van Pinxteren, L.A., Okkels, L.M., Rasmussen, P.B., and Andersen, P. (2001). Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun 69, 2773-2778.
19. Pablos-Mendez, A., Raviglione, M.C., Laszlo, A., Binkin, N., Rieder, H.L., Bustreo, F., Cohn, D.L., Lambregts-van Weezenbeek, C.S., Kim, S.J., Chaulet, P., and Nunn, P. (1998). Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 338, 1641-1649.
20. Palendira, U., Kamath, A.T., Feng, C.G., Martin, E., Chaplin, P.J., Triccas, J.A., and Britton, W.J. (2002). Coexpression of interleukin-12 chains by a self-splicing vector increases the protective cellular immune response of DNA and Mycobacterium bovis BCG vaccines against Mycobacterium tuberculosis. Infect Immun 70, 1949-1956.
21. Palma, C., Iona, E., Giannoni, F., Pardini, M., Brunori, L., Orefici, G., Fattorini, L., and Cassone, A. (2007). The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but nonprotective Th1 immune response in mice. Cell Microbiol 9, 1455-1465.
22. Rapeah, S., and Norazmi, M.N. (2006). Immunogenicity of a recombinant Mycobacterium bovis bacille Calmette-Guerin expressing malarial and tuberculosis epitopes. Vaccine 24, 3646-3653.
23. Taracha, E.L., Bishop, R., Musoke, A.J., Hill, A.V., and Gilbert, S.C. (2003). Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses. Infect Immun 71, 6906-6914.
24. Tollefsen, S., Tjelle, T., Schneider, J., Harboe, M., Wiker, H., Hewinson, G., Huygen, K., and Mathiesen, I. (2002). Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation. Vaccine 10, 3370-3378.
25. Villarreal-Ramos, B., Reed, S., McAulay, M., Prentice, H., Coffey, T., Charleston, B.C., and Howard, C.J. (2006). Influence of the nature of the antigen on the boosting of responses to mycobacteria in M. bovis-BCG vaccinated cattle. Vaccine 24, 6850-6858.
26. Wang, Q.M., Sun, S.H., Hu, Z.L., Yin, M., Xiao, C.J., and Zhang, J.C. (2004). Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting. Vaccine 22, 3622-3627.
27. Wiker, H.G., Mustafa, T., Malen, H., and Riise, A.M. (2006). Vaccine approaches to prevent tuberculosis. Scand J Immunol 64, 243-250.
28. Xu, Y., Wang, B., Chen, J., Wang, Q., Zhu, B., Shen, H., Qie, Y., Wang, J., and Wang, H. (2006). Chimaeric protein improved immunogenicity compared with fusion protein of Ag85B and ESAT-6 antigens of Mycobacterium tuberculosis. Scand J Immunol 64, 476-481.
29. Zhang, X., Divangahi, M., Ngai, P., Santosuosso, M., Millar, J., Zganiacz, A., Wang, J., Bramson, J., and Xing, Z. (2007). Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene. Vaccine 25, 1342-1352.